Rexulti is covered by Medicare and now FDA approved to treat agitation. But, advocates want Medicare coverage for other drugs shown to slow cognitive decline in Alzheimer’s.
Rexulti is covered by Medicare and now FDA approved to treat agitation. But, advocates want Medicare coverage for other drugs shown to slow cognitive decline in Alzheimer’s.